We are live on
!
Find out more
Schroder Investment Management Group Portfolio holdings
AUM
$122B
1-Year Est. Return
29.27%
This Fund
S&P 500
This Quarter
Est. Return
+6.67%
1 Year Est. Return
+29.27%
3 Year Est. Return
+98.87%
5 Year Est. Return
+131.84%
10 Year Est. Return
+513.68%
AUM
$97.6B
AUM Growth
+$6.9B
(+7.6%)
Cap. Flow
+$1.87B
Cap. Flow
% of AUM
1.91%
Top 10 Holdings %
Top 10 Hldgs %
27.39%
Holding
1,284
New
96
Increased
497
Reduced
493
Closed
87
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tencent Music
TME
|
+$517M |
| 2 |
UnitedHealth
UNH
|
+$420M |
| 3 |
Apple
AAPL
|
+$341M |
| 4 |
GE Vernova
GEV
|
+$236M |
| 5 |
Cadence Design Systems
CDNS
|
+$177M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$313M |
| 2 |
Merck
MRK
|
+$295M |
| 3 |
PepsiCo
PEP
|
+$216M |
| 4 |
Elevance Health
ELV
|
+$201M |
| 5 |
ConocoPhillips
COP
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.16% |
| 2 | Consumer Discretionary | 12.47% |
| 3 | Financials | 11.84% |
| 4 | Healthcare | 11.71% |
| 5 | Communication Services | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Bio-Rad Laboratories Class A
BIO
$9.53B
| $1.15M | ﹤0.01% |
3,465
+49
| +1% | +$15.6K |
|
952
NetEase
NTES
$81.9B
| $1.14M | ﹤0.01% |
12,237
-1,708
| -12% | -$149K |
|
953
Loews
L
$23.1B
| $1.14M | ﹤0.01% |
14,487
-45,083
| -76% | -$3.54M |
|
954
PureCycle Technologies
PCT
$1.54B
| $1.12M | ﹤0.01% |
117,487
-82,641
| -41% | -$553K |
|
955
Q2 Holdings
QTWO
$3.95B
| $1.11M | ﹤0.01% |
13,892
-2,657
| -16% | -$187K |
|
956
Crown Holdings
CCK
$13.1B
| $1.09M | ﹤0.01% |
11,554
+862
| +8% | +$74.2K |
|
957
CRISPR Therapeutics
CRSP
$5.23B
| $1.09M | ﹤0.01% |
23,000
| – | – |
|
958
Syndax Pharmaceuticals
SNDX
$1.81B
| $1.09M | ﹤0.01% |
+57,565
| New | +$1.19M |
|
959
Procore
PCOR
$8.93B
| $1.09M | ﹤0.01% |
+17,600
| New | +$1.08M |
|
960
Ameren
AEE
$29.8B
| $1.08M | ﹤0.01% |
12,482
-3,089
| -20% | -$247K |
|
961
Caesars Entertainment
CZR
$6.06B
| $1.07M | ﹤0.01% |
25,676
+1,401
| +6% | +$52.5K |
|
962
Akamai
AKAM
$16.8B
| $1.05M | ﹤0.01% |
10,363
-179
| -2% | -$17.4K |
|
963
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
| $1.04M | ﹤0.01% |
17,917
-1,096
| -6% | -$59.3K |
|
964
Solventum
SOLV
$14.3B
| $1.01M | ﹤0.01% |
14,881
-6,256
| -30% | -$376K |
|
965
Olema Pharmaceuticals
OLMA
$911M
| $1M | ﹤0.01% |
82,187
-77,552
| -49% | -$991K |
|
966
Mine Safety
MSA
$7.44B
| $995K | ﹤0.01% |
5,623
+776
| +16% | +$141K |
|
967
SPS Commerce
SPSC
$2.7B
| $990K | ﹤0.01% |
+5,150
| New | +$1.01M |
|
968
EyePoint Inc
EYPT
$1.13B
| $989K | ﹤0.01% |
123,933
-1,189
| -1% | -$10.4K |
|
969
HealthEquity
HQY
$8.83B
| $969K | ﹤0.01% |
11,841
+551
| +5% | +$42.5K |
|
|
FEDU
970
Four Seasons Education Depositary Shares Rep 10 Ordinary Shares
FEDU
$15.6M
| $969K | ﹤0.01% |
81,771
-8,674
| -10% | -$115K |
|
971
Revvity
RVTY
$12.9B
| $955K | ﹤0.01% |
7,575
-503
| -6% | -$59.1K |
|
972
Carlyle Group
CG
$17.4B
| $953K | ﹤0.01% |
21,870
+11,178
| +105% | +$469K |
|
973
LPL Financial
LPLA
$29.2B
| $949K | ﹤0.01% |
4,080
| – | – |
|
974
Brady Corp
BRC
$4.48B
| $949K | ﹤0.01% |
12,615
-48,084
| -79% | -$3.42M |
|
975
Harley-Davidson
HOG
$2.78B
| $946K | ﹤0.01% |
24,032
+1,824
| +8% | +$66.1K |
|
Similar funds
VAM
Schroder Investment Management Group's Q3 2024 Portfolio in Review
As of Q3 2024, Schroder Investment Management Group held 1,284 positions worth $97.6B, up 7.6% from $90.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Schroder Investment Management Group's Q3 2024 filing shows 96 new, 497 increased, 493 reduced and 87 closed positions. Its largest new stake was iShares MSCI China ETF: 810,155 shares worth $41.3M. The largest sale was Charles Schwab, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Financials.
- Schroder Investment Management Group's largest Q3 2024 buy was iShares MSCI China ETF: 810,155 shares worth $41.3M.
- Schroder Investment Management Group added most to Tencent Music in Q3 2024, an estimated $517M increase.
- Schroder Investment Management Group's biggest Q3 2024 reduction was Charles Schwab, cutting an estimated $313M.
- Schroder Investment Management Group fully exited TE Connectivity in Q3 2024, selling an estimated $90.8M.
- Schroder Investment Management Group's ten largest holdings make up 27% of its $97.6B portfolio in Q3 2024.
- Schroder Investment Management Group opened 96 new positions and closed 87 in Q3 2024.
- Schroder Investment Management Group's portfolio value rose 7.6% quarter-over-quarter to $97.6B.
Based on Schroder Investment Management Group's 13F filing for Q3 2024, filed 13 Nov 2024.